Document Detail

Management of cardiac arrhythmia.
MedLine Citation:
PMID:  18478865     Owner:  NLM     Status:  MEDLINE    
Cardiac arrhythmia management has advanced substantially and many patients are now being offered curative treatment. There is still much to do and therefore substantial research opportunities. Technical advances with better imaging and mapping datasets, improved ablation catheters and new devices to protect against SCD are all on the horizon. The genetic contribution to arrhythmias is now firmly established and preclinical functional studies will lead to more detailed phenotyping of patients leading to more rational targeting of drugs, catheter ablation and devices.
Andrew Grace
Related Documents :
23173855 - Coronary sinus approach to repair an intracardiac ventricular pseudoaneurysm.
1385715 - Post-mortem observations of a recent radiofrequency catheter ablation site.
20230445 - A latent atrioventricular decrementally conducting accessory pathway mimicking a bystan...
11400085 - Fluoroscopically assisted thromboembolectomy: should it be routine?
17895555 - Prognostic value of myocardial perfusion single-photon emission computed tomography for...
10197675 - Should the pericardium be closed routinely after heart operations?
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Clinical medicine (London, England)     Volume:  8     ISSN:  1470-2118     ISO Abbreviation:  Clin Med     Publication Date:  2008 Apr 
Date Detail:
Created Date:  2008-05-15     Completed Date:  2008-08-14     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101092853     Medline TA:  Clin Med     Country:  England    
Other Details:
Languages:  eng     Pagination:  175-6     Citation Subset:  IM    
Papworth Hospital, Cambridge.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Anti-Arrhythmia Agents / therapeutic use
Arrhythmias, Cardiac / diagnosis,  therapy*
Catheter Ablation / methods
Death, Sudden, Cardiac / prevention & control
Defibrillators, Implantable
Risk Assessment
Reg. No./Substance:
0/Anti-Arrhythmia Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Contemporary percutaneous coronary intervention--30 years in the making.
Next Document:  What is musical genius?